KRAS is commonly mutated in sporadic CRCs (35–45%) [158,162,163] and is associated with poor prognosis [164,165,166]; according to the adenocarcinoma sequence, KRAS mutations occur after APC mutations [10]. The gene discussed is KRAS; the disease is adenocarcinoma.